By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 109.09 |
Change Today | $ 1.72 |
% Change | 1.60 % |
52 Week High | $117.41 |
52 Week Low | $63.15 |
Volume | 7,929,947 |
Shares Issued | 1,246.00m |
Market Cap | $135,926m |
RiskGrade | 120 |
Strong Buy | 10 |
Buy | 9 |
Neutral | 8 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
16:00 | 2,351,650 @ $109.09 |
16:00 | 340 @ $109.11 |
16:00 | 100 @ $109.11 |
15:59 | 460 @ $109.11 |
15:59 | 1,440 @ $109.11 |
You are here: research